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Using a reovirus reverse genetics system, we have identified the 5V sequences required of an engineered s2 ssRNA for efficient
incorporation into the dsRNA genome of Reovirus. Employing an engineered, functionally active reovirus S2/CAT gene retaining the first
198 5V terminal nucleotides and the last 284 3V terminal nucleotides of the wild-type S2 segment, we have determined the 5V sequence required
by a ssRNA to be recognized, replicated to dsRNA, and stably incorporated into an infectious reovirus. The 5V sequence retains 96
nucleotides of the wild-type s2 ssRNA and a predicted sequence–structure element. Within these 96 nucleotides, we have identified three
nucleotides A-U-U at positions 79–81 that are essential for the incorporation of in vitro-generated ssRNAs into new reovirus progeny viral
particles. This study establishes a firm foundation for additional investigation into the assortment and encapsidation mechanism of all 10
ssRNAs into the dsRNA genome of reovirus.
D 2004 Elsevier Inc. All rights reserved.
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The name Reovirus includes the acronym reo-(respira-
tory enteric orphan), so designated because reovirions can
be isolated from the respiratory and intestinal tracts of both
warm- and cold-blooded animals, but have not been
associated with specific clinical diseases. There are three
major mammalian Reovirus serotypes: serotype 1, serotype
2, and serotype 3 (ST1, ST2, ST3).
The genome of Reovirus consists of 10 unique segments
of double-stranded RNA (Shatkin et al., 1968). The
segments are classified according to size. Three size classes
exist: large (L) segments consist of about 3800 base pairs
each, medium (M) segments consist of about 2200 base
pairs each, and small (S) segments consisting of about
1100–1400 base pairs each. Each virion contains three L
(L1, L2, L3), three M (M1, M2, M3), and four S (S1, S2,
S3, S4) segments. Reovirions contain a transcriptase that0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.08.026
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E-mail address: roner@uta.edu (M.R. Roner).transcribes the genome segments, by way of a conservative
mechanism, into ssRNA molecules. These molecules are the
(+) strand and function as mRNA. Each of the virions’ RNA
transcripts can code for the synthesis of at least one
polypeptide. Twelve reovirus-specific polypeptides are
synthesized in infected cells and are divided into three size
classes: the lambda (E) class, containing the high molecular
weight polypeptides (E1, E2, E3), the mu (A) class,
containing the intermediate size polypeptides (A1, A1c, A2,
ANS), and the sigma (j) class, containing the low molecular
weight polypeptides (j1, j1s j2, jNS, j3).
The dsRNA viruses are grouped into three families: the
Reoviridae, Birnaviridae, and Cystoviridae. Within the
family Reoviridae, in addition to reovirus (Joklik and Roner,
1995; Roner et al., 1995), extensive work has been done with
bluetongue virus (Roy, 1996) and rotavirus (Estes, 1996;
Patton and Spencer, 2000). What remains true for each of
these viruses is the lack of a complete explanation for how a
multi-segmented dsRNAvirus is able to replicate, assort, and
package multiple RNA segments to yield progeny virus
particles with particle to PFU ratios approaching 1.0
(Spendlove et al., 1970).04) 348–360
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at their 5V ends and the pentanucleotide -UCAUC at the 3V
ends of their plus strands. This conservation of nucleotides
is also present in the ssRNAs of the other members of the
Reoviridae family, with all the genome segments of a
specific virus possessing identical nucleotides at their 5V and
3V termini, but with these nucleotides being different from
family to family.
This evolutionary conservation of the terminal nucleo-
tides suggests a functional importance for these sequences.
Extensive work with rotavirus has identified a possible
secondary structure in rotavirus ssRNAs that involves an
interaction between the 5V and 3V ends of these RNA
molecules. This structure has been suggested to represent a
replication–packaging structure (Patton and Spencer, 2000).
Although such a structure may be possible for reovirus
ssRNA molecules, we have been able to demonstrate a
biologically functional 5V sequence–structure, while retain-
ing a constant 3V sequence.
We previously constructed a cDNA template that, upon
transcription, yields a recombinant reovirus s2 ssRNA
containing the CAT gene (Roner and Joklik, 2001). This
template can be transcribed in vitro or in vivo, by T7 RNA
polymerase, to yield an RNA transcript that possesses the
authentic 5V terminal sequence, including a cap (in vitro
only), of the reovirus s2 mRNA found in vivo. The wt s2
sequence, ending at nucleotide #198, is fused in-frame to the
CAT gene coding sequence (752 bp) (Antczak et al., 1982).
The 3V terminus of the CAT gene is fused to the 3V S2 gene
sequence beginning at nucleotide #1047 of the wt S2 gene.
The 3V terminus of the S2 gene, including the untranslated
sequence, is fused to the Hepatitis Delta Virus (HDV)
ribozyme sequence (Been et al., 1992). T7 RNA tran-
scription is terminated with the T7 terminator (T7 T)
sequence located 3V of the construction.
Following transcription of this construction, an RNA is
generated that contains the first 198 5V nucleotides of the
reovirus ST3 s2 ssRNA sequence fused, in frame, to the
CAT gene. The RNA terminates at the 3V end with 284
nucleotides of the reovirus ST3 s2 ssRNA sequence. The
terminal 3V nucleotides of the RNA are identical to those
found in the ST3 s2 ssRNA in vivo. The HDV ribozyme is
fused in such a fashion to the s2 sequence that when the
ribozyme undergoes auto-cleavage a terminal C on the 3V
ends of the RNA remains. This construction of the cDNA
template results in the 3V terminal sequence of -UCAUC 3V.
It has been proposed, based on studies using temperature-
sensitive reovirus mutants (Coombs, 1998; Fields et al.,
1972), that a major step in the replication of reovirus, and
presumably all segmented dsRNA viruses, is the replication
of parental viral ssRNAs to generate 10 dsRNA segments.
All ts mutants are dsRNA (+) or dsRNA (), indicating that
either all 10 dsRNAs are generated or no dsRNAs are
generated; never has it been observed that a limited set of
ssRNAs can replicated to dsRNA (Antczak and Joklik,
1992).For this study, we defined the replication signals to be
those signals that when absent or mutated prevent the
formation of a dsRNA copy of our mutated ssRNA in vivo.
An additional major step in the reovirus replication cycle is
the correct assortment of either 10 ssRNAs or 10 dsRNAs
into genomic sets that are then incorporated into progeny
viral particles. We defined the encapsidation signals to be
those signals that, when absent or mutated, prevent the
formation of infectious progeny virus, containing our
mutated dsRNA genome segment.
We began this study with the hypothesis that we could
distinguish between the replication and encapsidation
signals using our system. As our data demonstrate, the
two signals, if they exist, cannot be distinguished independ-
ently from each other using our system. We have not been
able to detect the replication of one of our engineered
ssRNAs to a dsRNA molecule independent of the simulta-
neous incorporation of this dsRNA molecule into a progeny
virus. This finding supports the work by Antczak et al. that
in vivo, replication of reovirus ssRNA molecules occurs
after assortment into ssRNA protein complexes, and results
in the formation of equal-molar amounts of each dsRNA
genome segment. As with Phi 6 (Mindich, 1999; Kainov et
al., 2003), it appears that reovirus ssRNAs must be
assembled into complete sets of ssRNAs, at which time
all are replicated to dsRNA genome segments.
Research with rotavirus ssRNAs has identified sequences
in the 5V and 3V terminal sequences of these ssRNAs that are
required for efficient minus strand synthesis to yield a
dsRNA molecule (Barro et al., 2001; Deo et al., 2002). The
rotavirus systems developed to date are not yet capable of
generating infectious virus containing engineered dsRNA
genome segments. Unlike the reovirus system, the rotavirus
systems may not be capable of reproducing the in vivo
recognition conditions required to generate an infectious
virus. Our results with reovirus represent an in vivo
extension of the rotavirus systems, and as such agree with
those found with the rotavirus systems.
This work identifies the 5V upstream flanking sequence
required to ensure efficient incorporation of an engineered
s2 ssRNA into the reovirus genome and, therefore,
represents a major step in the process of developing a
reverse genetics system for reovirus that supports the
genetic engineering of any reovirus genome segment.Results
Construction of s2-CAT cDNA templates and transcription
to yield the engineered ssRNAs
The purpose of this investigation was to examine the 5V s2
ssRNA sequence to define the sequence required for
incorporation into a stable recombinant reovirus utilizing
our reverse genetics system (Roner and Joklik, 2001; Roner
et al., 1990). We have previously demonstrated incorporation
Fig. 1. Complete nucleotide sequence of the ssRNA produced from the cDNA template pS2CAT198 using a T7 RNA polymerase promoter and T7 terminator. The inclusion of a HDV ribozyme results in internal
cleavage of this RNA as indicated and generates a biologically active ssRNAwith 5Vand 3V termini identical to the wt s2 ssRNA. As described in Materials and methods, all ssRNAs were sequenced to confirm the
5V and 3V ends of these RNAs.
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M.R. Roner et al. / Virology 329 (2004) 348–360 351of an engineered s2 ssRNA that contained 198 nucleotides
from the wild-type s2 ssRNA 5Vend and 284 nucleotides from
the wild-type s2 ssRNA 3V end into the reovirus genome
(Roner and Joklik, 2001). In this study, we conducted an
analysis of the 198 5V terminal nucleotides of this engineered
reovirus s2 ssRNA, the 284 s2 nucleotides at the 3V end
remained the same for all constructs. To accomplish this, we
have generated a large collection of cDNA templates based
on our original template pS2CAT13 (Roner and Joklik,
2001). A Pst1 restriction site was added to the 3V terminus of
pS2CAT13; no other modifications to the original plasmid
were made. The addition of a Pst1 site allowed us to linearize
the plasmid resulting in a 2-fold increase in the yield of T7-
generated ssRNA versus using a circular template. The
resulting plasmid was named pS2CAT198. See Fig. 1.
The plasmid contains a T7 polymerase promoter placed
at the 5V end of the construct and the T7 terminator at the 3V
end. To achieve the appropriate cleavage of the modified s2
ssRNA from the transcript, the HDV ribozyme sequence
was placed to ensure the presence of the universal reovirus
RNA 3V terminal sequence -UCAUC. The ssRNA generated
from this cDNA is 1234 nucleotides long, 97 nucleotides
shorter than the wt s2 RNA. It encodes a j2-CAT fusion
protein that possesses 66 j2 AAs at its N-terminus and does
not exercise protein j2 function, but demonstrates CAT
catalytic activity (Roner and Joklik, 2001). The remaining
cDNA templates used in this study were generated using
site-directed mutagenesis to delete the indicated s2
5Vsequences from the pS2CAT198 cDNA template. See
Fig. 2.
5V S2 sequences required for biological activity
From our earlier work, we knew that 198 nucleotides
from the wt s2ssRNA 5V end and 284 nucleotides from the 3V
end are sufficient to enable a ssRNA to be incorporated as a
dsRNA genome segment into the reovirus genome. As we
have previously noted and can be seen in Fig. 2, the
s2CAT198 dsRNA migrates slower than the ST3 wt s2
dsRNA, although it is 97 nucleotides shorter (Roner and
Joklik, 2001). This is not unexpected, as several reovirus
dsRNA segments do not migrate according to size.
To determine the minimal 5V s2 ssRNA sequence that
retains this activity, we began by reducing the 5V sequence in
steps of 24 nucleotides from nucleotide 198. The ssRNAs
generated from these cDNA templates were lipofected into
cells supplying functional j2 protein as indicated using the
reovirus infectious RNA system described in Materials and
methods. We then examined the ssRNA, dsRNA, and CAT-
dsRNA using Northerns, 12 h following lipofection. Thirty-
six hours later, samples were harvested and plaque assays
preformed as described. Generated viruses were isolated
using plaque assays on L-ST3.S2 cell monolayers and
replaqued three times for purity. The dsRNA genome
segments of individual purified viruses were labeled in vivo
with 32P following infection of L-ST3.S2 cells and analyzedby SDS-PAGE. Autoradiograms of these cells demonstrat-
ing migration rates or patterns of individual viruses are
shown in the bottom panels for each deletion. See Fig. 2.
The first ssRNA generated from pS2CAT198 contains the
identical 5V s2 sequence up to and including nucleotide 174.
The next cDNA template would yield a ssRNAwith 150 s2 5V
nucleotides, the next 126, and so forth. These deletions are
summarized in the first panel of Fig. 2. The removal of 24
nucleotides ensured that the j2 start codon remained in-frame
with the CAT start codon. Therefore, translation of the
generated ssRNA continued to yield a j2-CAT fusion protein
with CAT activity that could be detected in vitro and in vivo.
All viruses generated with these templates would express
CAT activity when used to infect cells. We continued with
these deletions until we reached a 5V length of 30 nucleotides.
The next deletion we made contained 21 5Vs2 nucleotides.
This represents the minimum s2 sequence required to use and
retain the j2 start codon and an in-frame CAT. The next
deletion left only the four nucleotides conserved among all
reovirus ssRNAs, 5VGCUA-. This ssRNA contained an out-
of-frame start codon and therefore did not express j2 or CAT
activity. As can be seen in Fig. 2, this RNA and all the
engineered ssRNAs were detected in vivo following lip-
ofection to generate virus. As can be seen in Fig. 2 and
summarized in Table 1, ssRNAs with at least 102 s2 5V-
derived nucleotides were subsequently replicated to dsRNA
and incorporated into stable recombinant reoviruses. In Table
1, recombinant ssRNAs were generated from each cDNA
with the indicated length of reovirus S2 5V and 3V sequences
flanking the CAT gene. These ssRNAs were then used to
supplement a set of nine ssRNAs and the now completed set
of 10 ssRNAs used in the infectious RNA system to generate
recombinant reoviruses containing this S2 CAT genome
segment. The 5V ssRNA sequence capable of being replicated
to dsRNA and incorporated in a recombinant reovirus is 96
nucleotides. Cat activity was measured with the CAT-ELISA
from Roche Molecular Biochemicals (#1363726). Clones
pS2CAT97, 95, 94, 92, and 91 are negative for CAT activity
because they are out of frame with the j2 AUG start.
To confirm and extend these findings, we generated a
second set of ssRNAs using deletion increments of six
nucleotides. These deletions are summarized in the center
panel of Fig. 2.We continued our analysis down to a length of
84 nucleotides. As can be seen in Fig. 2 and summarized in
Table 1, ssRNAs with at least 96 5V nucleotides were
biologically active and replicated to dsRNA, and subse-
quently incorporated into progeny virus that was isolated and
purified.
We then generated a series of cDNA templates with
single nucleotide deletions around nucleotide 96. These
deletions are summarized in the right panel of Fig. 2. As can
be seen in Fig. 2 and summarized in Table 1, the s2 5V
ssRNA sequence required to ensure incorporation of a
recombinant ssRNA into the reovirus genome was 96
nucleotides. Engineered ssRNAs containing 96 or 97
nucleotides are replicated to dsRNA and incorporated into
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Table 1
Summary of the biological activities of recombinant ssRNAs used to drive the reovirus infectious RNA system
cDNA clone Length of 5V S2
sequence
Length of 3V S2
sequence
CAT activity
(pg/ml)
ssRNA
detected
dsRNA
detected
Engineered RNA
incorporated into
infectious virus
pS2CAT198 198 284 64 + + +
pS2CAT174 174 284 64 + + +
pS2CAT150 150 284 32 + + +
pS2CAT126 126 284 32 + + +
pS2CAT102 102 284 64 + + +
pS2CAT78 78 284 64 +  
pS2CAT54 54 284 64 +  
pS2CAT30 30 284 32 +  
pS2CAT21 21 284 64 +  
pS2CAT4 4 284 b4 +  
pS2CAT192 192 284 32 + + +
pS2CAT186 186 284 64 + + +
pS2CAT180 180 284 64 + + +
pS2CAT168 168 284 32 + + +
pS2CAT162 162 284 32 + + +
pS2CAT156 156 284 64 + + +
pS2CAT150 150 284 64 + + +
pS2CAT144 144 284 64 + + +
pS2CAT138 138 284 32 + + +
pS2CAT132 132 284 64 + + +
pS2CAT120 120 284 64 + + +
pS2CAT114 114 284 64 + + +
pS2CAT108 108 284 64 + + +
pS2CAT102 102 284 64 + + +
pS2CAT96 96 284 64 + + +
pS2CAT90 90 284 32 +  
pS2CAT84 84 284 32 +  
pS2CAT97 97 284 b4 + + +
pS2CAT95 95 284 b4 +  
pS2CAT94 94 284 b4 +  
pS2CAT93 93 284 64 +  
pS2CAT92 92 284 b4 +  
pS2CAT91 91 284 b4 +  
M.R. Roner et al. / Virology 329 (2004) 348–360 353virus while ssRNAs containing 95–91 nucleotides are
detected in vivo but are not replicated to dsRNA or
incorporated in progeny virus.
Identification of a conserved A-U-U-sequence associated
with a hairpin loop RNA structure
An analysis of the 5V RNA sequences of the
engineered s2 ssRNAs that are replicated and incorpo-
rated into infectious progeny virus particles, using theFig. 2. Survey of the minimum 5V terminal s2 ssRNA nucleotides required for bio
single nucleotide deletions. At the top is the sequence of the 5V nucleotides of th
template pS2CAT198. The sequence includes the first 18 nucleotides of the CAT c
Fig. 1. A line connects the last retained s2 nucleotide in the displayed sequence to t
Within each panel, the ssRNA, dsRNA, and CAT dsRNA panels are Northerns ana
ssRNAs and the ssRNA obtained following transcription of the indicated cDNA
generated by in vivo labeling with 32P of the dsRNA genome segments of an isolat
generated following lipofection was first triple-plaque purified. Deletions were mad
frame CAT fusion protein until 30 nucleotides remained; pS2CAT21 is a nine nu
preserves the conserved four nucleotides (GCUA) of reovirus ssRNAs and uses th
blocks of six nucleotides to preserve the authentic j2 AUG start and in-frame C
blanket the region between nucleotides 97 and 90 around nucleotide 96, the sh
Materials and methods, all ssRNAs were sequenced or analyzed to confirm the 5program RNA Structure, revealed a possible single-
stranded region of the RNA -A-U-U-located at nucleo-
tides 79–81 downstream of the 5V terminus. In Fig. 3, this
sequence is not predicted to be base-paired when the
complete ssRNA generated from pS2CAT96 is folded,
but is predicted to be base-paired when the complete
ssRNA generated from pS2CAT95 is folded. To examine
the possibility that we may have located a sequence–
structure in the 5V end of the reovirus s2 ssRNA that is
essential for replication and incorporation into a virus aslogical activity using 24 nucleotide deletions, six nucleotide deletions, and
e ssRNAs produced using the T7 RNA polymerase promoter and cDNA
oding sequence but does not show the 3V end of the ssRNA, this is shown in
he named cDNA plasmid, below which are displayed autoradiogram panels
lyzing RNA extracted from cells lipofected 12 h earlier with nine wild-type
template. The fourth and bottom panel of each set is an autoradiogram
ed progeny virus containing the indicated mutated S2 dsRNA. Progeny virus
e in blocks of 24 nucleotides to preserve the authentic j2 AUG start and in
cleotide deletion to preserve the AUG. The next deletion of 17 nucleotides
e CAT AUG to initiate translation (left panel). Deletions were continued in
AT fusion protein (center panel). Single nucleotide deletions were made to
ortest identified biologically active ssRNA to this point. As described in
V and 3V ends of these RNAs (right panel)..
-
Fig. 3. RNA structure predicted using the program RNA Structure (RNAstructure, Version 3.5) upon folding the complete s2 ssRNA generated from cDNA
pS2CAT96 and pS2CAT95. As indicated, for the pS2CAT96-encoded ssRNA, a loop structure is predicted to form that contains a single-stranded region of the
s2 ssRNA at nucleotides 79–81 with the sequence 5V-A-U-U-. For the pS2CAT95-encoded ssRNA, the s2 ssRNA at nucleotides 79–81 with the sequence 5V-A-
U-U- is predicted to be involved in base pairing. This RNA, as summarized in Table 1, is biologically inactive and not incorporated into a recombinant virus.
M.R. Roner et al. / Virology 329 (2004) 348–360354a dsRNA genome segment, we used site-directed muta-
genesis to alter this sequence. We mutated the A-U-U
sequence in two of our constructs, S2CAT198 and
S2CAT96, to (a) U-U-U, (b) A-A-U, or (c) A-U-A and
then tested them for virus generation. The resulting
cDNA templates were used to generate ssRNAs and then
to generate new recombinant viruses. When the A-U-U
sequence present in these ssRNAs is mutated to U-U-U,
A-A-U, or A-U-A, the resulting ssRNAs are functionally
bdeadQ; that is not replicated to dsRNA or incorporated
into virus particles. These results are shown in Fig. 4 and
summarized in Table 2. In Table 2, we summarize the
importance of an AUU containing hair-pin loop at
nucleotides 79–81, recombinant ssRNAs were generated
from each cDNA containing the indicated mutations of
this triplicate. These ssRNAs, identified as 198a, b, or c
and 96a, b, or c, have the A-U-U normally present at
positions 79–81 replaced with U-U-U (a), A-A-U (b), or
A-U-A (c). The mutated ssRNAs were then used to
generate recombinant reovirus containing this mutated S2
CAT genome segment. Only ssRNAs containing theoriginal AUU sequence were replicated to dsRNA and
subsequently incorporated into recombinant reoviruses.
Cat activity was measured with the CAT-ELISA from
Roche Molecular Biochemicals (#1363726).
As previously shown, all ssRNAs were detected
following lipofection and all ssRNAs replicated to
dsRNA were subsequently incorporated into progeny
viruses. These findings support our hypothesis that this
sequence A-U-U is very important to reovirus ssRNA
assortment and subsequent replication.Discussion
Our reverse genetics system is designed to permit the
stable incorporation of genetically engineered ssRNAs
into the reovirus genome and to isolate these genetically
engineered viruses. The properties of such a system
determine both its power and its limitations. The
system requires the introduction of 10 reovirus ssRNAs,
authentic or engineered; a protein–ssRNA mixture gen-
Fig. 4. Detection of virus-generation intermediates using the ssRNAs
generated from the single nucleotide cDNA templates outlined in Table 2
using the reovirus infectious RNA system. The ssRNA (in the top panel),
the dsRNA (in the next panel down), and the CAT dsRNA (the third panel
down) are shown utilizing Northerns analyzing RNA extracted from cells
lipofected 12 h earlier with nine wild-type ssRNAs and the ssRNA obtained
following transcription of the indicated cDNA template. The fourth and
bottom panels are an autoradiogram following SDS-PAGE generated by in
vivo labeling with 32P of the dsRNA genome segments of an isolated
progeny virus containing the indicated mutated S2 dsRNA. Progeny virus
generated following lipofection was first triple-plaque purified. Single-
stranded RNAs from templates s2CAT198a–c and s2CAT96a–c did not
produce virus and the virus dsRNA autoradiogram contains 32P-labelled
uninfected cell lysates in these lanes.
M.R. Roner et al. / Virology 329 (2004) 348–360 355erated by in vitro translation of these ssRNAs; and upon
introduction of these materials into a cell, infection with
a helper virus, usually reovirus serotype 2 (Roner et al.,
1990).
The use of a helper virus introduces the possibility that
reassortment could occur between the introduced ssRNAs
and the helper serotype 2 ssRNAs. This reassortment has
never been detected in the thousands of lipofections we have
screened, but makes examining the genomes of progenyviruses a requirement. The requirement for a helper virus
can make it difficult to use this system in its current form to
examine the blipofected-virus-generating-cellQ. Due to the
presence of replicating reovirus ST2 helper virus, the ST3
replication events may be obscured.
To efficiently incorporate a genetically engineered
genome into a reovirus with our system, we have had to
remove a ssRNA from the set of 10 wt ssRNAs that we use to
drive the reaction (Roner and Joklik, 2001). This produces a
reconstituted bsetQ of 10 ssRNAs composed of 9 wt ssRNAs
and one engineered ssRNA.
To date, we have not been successful at isolating a
recombinant reovirus generated by driving the system with
11 ssRNAs—10 wt and 1 altered. Reovirus appears capable
of brecognizingQ the wt 10 ssRNAs as a bsetQ and does not
permit the efficient replacement of a member of the bsetQ
with an added ssRNA. This is in contrast to what has been
found when cells are co-infected with two serotypes of
intact reovirus. Under these conditions, genome reassortants
form readily and new bsetsQ of 10 dsRNAs are produced
(Moody and Joklik, 1989). As we continue to expand this
work, we hope to provide an explanation for this apparent
paradox.
The method we have developed to insert altered
genome segments into the reovirus genome involves
selective destruction of an individual reovirus ssRNA
using RNase H and its replacement with an engineered
ssRNA (Gaillard and Joklik, 1985; Roner and Joklik,
2001; Roner et al., 1990). This method works well and
permits removal of 90–95% of the targeted ssRNA (Roner
and Joklik, 2001). When this depleted ssRNA mixture is
supplemented with an engineered RNA like our
pS2CAT198 derived ssRNA, virus yield from our system
is reduced to approximately 120 viruses for 106 cells from
a yield of 105 viruses for 106 cells when the wt set of 10
ssRNAs is used. We suspect that this is due to the quality
of our ssRNA and the j2 protein level produced by our
engineered L-ST3.S2 cells.
The quality of purified ST3 virus and the ssRNA
generated from activated cores represent key factors
contributing to the success of this system and their
importance cannot be overstated. Most of our failed
lipofection attempts can be traced to poor quality ssRNA
preparations. As we have described, purification of
reovirus from infected L929 cell cultures, using at least
four Freon extractions, is required to ensure a clean virus
preparation (Smith et al., 1969). In addition, following in
vitro transcription using viral cores (Roner, 1999), we
always test the quality of our ssRNA by sequencing 200
nucleotides of two or more of the 10 ssRNAs using
reverse transcriptase (Wiener et al., 1989). If the ssRNA
preparation cannot be sequenced to yield easily readable
results, the ssRNA will not yield virus in vivo using our
system.
We generally select all of the clones, approximately
100 viruses, produced following this type of virus
Table 2
Summary of the biological activities of recombinant ssRNAs mutated at a proposed stem-loop structure
cDNA clone 5V length 3V length Sequence
79–81
CAT activity
(pg/ml)
ssRNA
detected
dsRNA
detected
Engineered RNA
incorporated into
infectious virus
pS2CAT198 198 284 A-U-U 64 + + +
pS2CAT198a 198 284 U-U-U 32 +  
pS2CAT198b 198 284 A-A-U 64 +  
pS2CAT198c 198 284 A-U-A 64 +  
pS2CAT96 96 284 A-U-U 64 + + +
pS2CAT96a 96 284 U-U-U 64 +  
pS2CAT96b 96 284 A-A-U 64 +  
pS2CAT96c 96 284 A-U-A 32 +  
M.R. Roner et al. / Virology 329 (2004) 348–360356generation experiment and analyze their genomes by
SDS-PAGE as described (Roner and Joklik, 2001).
Routinely, 5–15% of the viruses contain the mutated
gene and can be replaque purified and grow to high-titer
stocks. The remaining 85–95% are wt viruses generated
by the incorporation of the 5–10% of the wt ssRNA not
removed through our RNase H treatment. As displayed in
Fig. 2, we analyze ssRNA, dsRNA, and CAT-dsRNA 12
h following lipofection. At this point, only very small
amounts of the wt ssRNA and dsRNA generated from
the remaining wt s2 ssRNA are occasionally detectable
by Northerns. By 48 h, the wt virus generated from this
RNA is out-replicating our newly generated recombinant
viruses.
To date, all the recombinant viruses we have generated
form plaques in 5 days, our screening criteria, although all
are smaller than wt ST3 plaques, and all are quickly
overwhelmed in mixed infections with wt virus. We have
tried to reduce the level of undigested ssRNA, but have
only succeeded in further reducing our total virus yield.
This may be due to subsequent degradation of the
remaining non-targeted nine ssRNAs as a result of
nonspecific binding of the DNA oligos to non-target
ssRNAs, followed by recognition and degradation by
RNase H. Using our system, a recombinant reovirus
containing a mutated genome segment can be generated
and isolated even though it may compete poorly with wt
virus.
If an engineered ssRNA is not incorporated into an
infectious virus, then the analysis of what went wrong
can be difficult because the helper virus is replicating and
producing virus in the cell. To avoid this problem, we
have elected to incorporate the CAT coding sequence into
our engineered ssRNAs. This permits us to examine the
lipofected cells in which virus should be generated to
learn the fate of our engineered ssRNA. For each attempt
to incorporate an engineered ssRNA into a reovirus
genome, we screen the lipofected cells for CAT ssRNA
and CAT dsRNA, as well as virus generation. We have
been able to detect all our engineered ssRNAs in
lipofected cells regardless of whether dsRNA or recombi-
nant virus is subsequently produced or not. This control
provides evidence that all our engineered ssRNAs arestable and that their failure to be replicated to dsRNA and
incorporated into progeny virus is the result of mutations
we have engineered and not differences in ssRNA
quality and stability. We have only detected CAT-dsRNA
in cells in which recombinant virus is subsequently
produced.
The ssRNA transcribed from the cDNA template
pS2CAT96 represents the 5V sequences preceding the CAT
gene, which are required for this ssRNA to be replicated to
dsRNA and incorporated into an infectious virus particle. The
recombinant virus that is generated will only undergo partial
replication depending upon the gene that is altered. For the
S2CAT virus we describe here, complete virus replication is
only possible in L929 cells that supply the S2 gene product
j2.
We have identified a possible sequence–structure
present in the 5V end of the reovirus s2 ssRNA that is
required for this ssRNA to be replicated to form a dsRNA
genome segment and for this genome segment to be
incorporated into a virus particle. RNA secondary structure
predictions indicate that this same sequence–structure may
be present in approximately the same 5V location in all 10
reovirus serotype 3 ssRNAs. In the future, we will analyze
the remaining nine reovirus ssRNAs and test RNA folding
in vivo.
It should be noted that a possible interaction between
the 5V and 3V sequences has not been extensively
examined. All of our 5V engineered ssRNAs contain a 3V
s2 ssRNA sequence length of 284 nucleotides. We have
demonstrated that these 284 nucleotides in combination
with at least 96 s2 5VssRNA nucleotides are sufficient to
direct replication to dsRNA and incorporation into
progeny virus. Future studies will examine the consequen-
ces of increasing the 3V terminal sequences to explore the
possibility that additional 3V sequences can rescue ssRNAs
with 5V sequences less than 96 nucleotides. In addition, we
are generating cDNA templates that reduce the 3V terminal
sequences to determine the minimum 3V flanking sequen-
ces required.
In summary, we have devised a powerful reverse
genetics system for members of the Reoviridae family.
We are in the process of applying this technology to
members of the genus orbivirus and rotavirus, where it
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of vaccine virus strains for use in both humans and
animals. The genetic modifications that this system permits
are mutations, deletions, and insertions; and it possesses
the advantage that the novel variants represent a high (10%
or more) proportion of the infectious reovirus system’s
virus yields.
We are in the process of constructing cell lines that
express other reovirus proteins, so that it will be possible
to genetically engineer any of the 10 reovirus genome
segments. The technology also permits reovirus to be
used as an abundantly replicating nonpathogenic expres-
sion vector that could find wide applicability in genetherapy and tumor oncolysis. Finally, the technology
provides a powerful system for basic studies on all
aspects of reovirus replication, molecular biology, and
molecular genetics.
Based on this study, it does not appear that the 5V and
3V flanking sequences that are required for incorporation
of an engineered or foreign gene in the reovirus genome
will limit the applications of this system. Currently, only
380 reovirus-specific nucleotides are required (96 +
284).We are extending our studies to include the larger
reovirus genome segments, and initial findings suggest
that foreign genes of 2000 nucleotides can be stably
incorporated into the reovirus genome.Materials and methods
Virus and cell lines
Reovirus ST3 strain Dearing and reovirus ST2 strain Lang were used. Both were grown in L929 mouse fibroblasts in
MEM or RPMI supplemented with 5% FBS. The recombinant viruses containing the CAT gene (ST3.S2.CAT) were
grown in L929 cells transformed with pHhAPr-1-neo (Gunning et al., 1987) that contained ST3 S2 cDNA under the
control of the human h-actin promoter. The transformed cells, L-ST3.S2 cells, expressed protein j2 at levels that were
sufficient to rescue tsC 447 (Ito and Joklik, 1972; Wiener et al., 1989), a ST3 virus mutant with a ts mutation in the S2
genome segment, and support growth of recombinant CAT-containing reoviruses (Roner and Joklik, 2001).
Engineering of reovirus s2 cDNA
As previously demonstrated, we can incorporate an engineered reovirus s2 ssRNA into the reovirus genome as a stable
dsRNA genome segment (Roner and Joklik, 2001). In this work, we deleted an internal 848 nucleotides from the wild-type s2
sequence and replaced this with the CAT gene coding sequence (752 bp). This allowed us to distinguish between the wt s2
RNA and our engineered s2 RNA, both by sequence analysis and functional CAT activity. The following is a diagram of the
S2-CAT cDNA template (pS2CAT198) that was inserted into pUC19.This template can be transcribed by T7 RNA polymerase to yield an RNA transcript that possesses the same 5V and 3V
terminal sequences as authentic S2 RNA. The 5V terminal S2 sequence ending at nucleotide 198 was fused, in frame, to
the CAT gene coding sequence (Roner and Joklik, 2001). The 3V terminus of the CAT sequence was fused to the 3V S2
sequence, beginning at bp 1047 (of the wild type s2 RNA); and the 3V terminus of the S2 sequence, including the
untranslated sequence, was fused to the Hepatitis Delta Virus (HDV) ribozyme sequence. Transcription by T7 RNA
polymerase was terminated with the T7 terminator sequence located 3V of this construct. Transcription of this construction
yielded an RNA that contained the 198 5V nucleotides of s2 RNA fused in frame to the CAT mRNA sequence followed
by the 284 3V terminal nucleotides of s2 RNA. This was achieved by inserting the HDV ribozyme sequence in such a
way that when the ribozyme underwent auto-cleavage, it left a terminal C at the 3V terminus. As a result, the 3V terminal
sequence of the transcript was the authentic reovirus RNA 3V terminal sequence -UCAUC. Recloning and subsequent
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2001).
The pS2CAT198 construct was transcribed in vitro using T7 RNA polymerase and the transcript was capped using m7
GpppG (Promega) to yield s2-CAT mRNA. It was translated in vitro using a rabbit reticulocyte lysate system (Promega)
and the lysate was found to contain CAT activity (CAT-ELISA, Boehringer Mannheim Corporation).
Mutagenesis of 5V s2 sequences preceding the CAT gene in construct pS2CAT198
Sequential deletion of the 5V 198 nucleotides was carried out using GeneEditor by Promega (#Q9280). This system
uses antibiotic selection to obtain a high frequency of mutants. Selection oligonucleotides provided with the GeneEditor
System encode mutations that alter the ampicillin resistance gene, creating a new additional resistance to the GeneEditor
Antibiotic Selection Mix. As directed by the manufacturer, we annealed the selection oligonucleotide to our pS2CAT198
double-stranded DNA template at the same time as a mutagenic oligonucleotide. Subsequent synthesis and ligation of the
mutant strand links the two oligonucleotides. The mutagenic oligonucleotides we selected were all 50 nucleotides long
(ACS), 25 nucleotides matching the 5V S2 or T7 promoter sequences depending upon the location of the sequence we
wished to retain, and 25 nucleotides matching the CAT nucleotide sequence. Using 25 perfectly matched nucleotides on
each side of the mismatched sequence we wished to loop-out and remove, we were able to remove 24, 6, or
individual nucleotides from the original pS2CAT198 sequence. For example, the sequence of the mutagenic
oligonucleotide used to delete 24 nucleotides from pS2CAT198 to yield pS2CAT174 was 5VCTGGATQ
AAGCCTTGGGAGGGGTTTAGATCCGAGATTTTCAGGAGCTAAGGV3.
Removal of wt s2 RNA
Wild-type s2 RNA was removed from the mixture of 10 ssRNA species as previously described (Roner et al., 1997).
The DNA oligonucleotide selected for this purpose was complementary to nucleotides 937–949; and 10 pmol was added
to 2 pmol of s2 RNA. After hybridization, the mixture was treated with RNAse H for 20 min. The RNA was extracted
three times with phenol/chloroform and precipitated with sodium acetate. Degradation of s2 RNA was confirmed by gel
electrophoresis of both the RNA and its translation products. The set of nine ssRNAs was supplemented with the
indicated s2-CAT RNAs and the resulting mixture was lipofected into L-ST3.S2 cells that were then infected with ST2
virus (Roner et al., 1990).
The reovirus infectious RNA system
The system was used as described (Roner and Joklik, 2001; Roner et al., 1990), but modified to use L-ST3.S2 cells that
express functional j2 protein in place of L929 cells. ST3 capped and methylated mRNA (always called ssRNA) was
transcribed by cores (Skehel and Joklik, 1969). After transcription, the cores were pelleted at 10000  g; the supernatant that
contained the ssRNAwas then made 0.5% with respect to sodium dodecyl sulfate (SDS) and extracted three times with phenol/
chloroform. The RNA was precipitated with Polyethylene glycol (PEG), reextracted three times with penol/chloroform, and
precipitated with 2.5 M ammonium acetate and ethanol. ssRNA prepared in this manner contained no residual infectious virus.
For all lipofections, we used 10 Al of Rabbit Reticulocyte Lysate (Promega #L4960) primed with 0.3–0.5 Ag of ST3 ssRNA
(obtained from in vitro transcription from reovirus cores) and 0.1 Ag of the indicated s2 ssRNA (obtained from in vitro
transcription using T7 RNA polymerase and the indicated cDNA template, Promega-RiboMAX-T7) in 1 Al H2O and 12 units
of RNasin Plus RNase Inhibitor (Promega) in 1 Al H2O. Translation was allowed to proceed for 1 h at 30 8C. After translation,
an additional 0.3–0.5 Ag of ST3 ssRNA in 1 Al H2O was added and the mixture was immediately added to 0.5 ml of MEM
containing penicillin and streptomycin and 50 Al of Lipofectin (Invitrogen Corporation). This mixture was immediately added
to PBS-washed monolayers of 106 mouse L929 fibroblasts in 6-well multiplates. After 6 h, this mixture was replaced with 0.25
ml of MEM containing 4  107 PFU of ST2 reovirus, and 1 h later 1.75 ml of MEM containing 5% fetal bovine serum was
added. After 24 h, the cells were harvested, washed twice in MEM, and sonicated in 2 ml of MEM, and virus in the sonicates
was titrated in mouse L929 fibroblast monolayers. To avoid detection of the ST2 helper virus, plaques were counted on day 5,
when plaques formed by ST2 virus were not yet detectable.
Virus titration or determination of CAT activity
Monolayers of lipofected and infected L-ST3.S2 cells were incubated at 37 8C for 5 days. Neutral red was added 24 h
before counting plaques (Roner et al., 1997). CAT activity in cell lysates was assayed using CAT ELISA (Boehringer
Mannheim Corporation).
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Twelve hours following lipofection of L929 or L-ST3.S2 cells with the indicated ssRNAs, protein translation mixture,
and infection with reovirus serotype 2 helper virus, total RNA was extracted from cell monolayers using Eppendorfs’
Perfect RNA Eukaryotic Mini kit and protocols. The ssRNA was electrophoresed in a formaldehyde denaturing gel using
Ambion, Inc’s NorthernMax kit. Following the manufacturer’s protocol, the ssRNA was transferred to a BrightStar-Plus
positively charged nylon membrane and UV-cross linked. Hybridization or detection was carried out at 40 8C according
to manufacturer’s directions using UltrahybTM buffer and 32P-labelled oligonucleotides. For detecting the ST3 s2 ssRNA,
the oligonucleotide (S2.3) 5VTTTCGAGCTTGTCCTCTTAAACTGTTGAGTCTGATCTGCC3V complementary to nucleo-
tides near the 3Vend of the s2 RNA was used. For detecting the s2/CAT ssRNA, the oligonucleotide (CAT.1)
5VTTTACGATGCCATTGGGATATATCGGTGGTATATCC3V complementary to CAT gene was used. The oligonucleotide
S2.3 was selected because it is 29% mismatched with the ST2 s2 sequence and, when used as a ssRNA probe, does not
detect the ST2 s2 ssRNA or S2dsRNA genome segment. The membrane was used to expose X-ray film.
Detection of reovirus s2 and CAT/s2 dsRNA in vivo
Twelve hours following lipofection of L929 or L-ST3.S2 cells with the indicated ssRNAs, protein translation mixture, and
infection with reovirus serotype 2 helper virus, total cell monolayers were harvested. The dsRNAwas electrophoresed in 7.5%
SDS-PAGE gels for 2650 V/h as described (Gaillard and Joklik, 1985). Following the protocol used for the ssRNA gels, the
dsRNA was transferred to a BrightStar-Plus positively charged nylon membrane and UV-cross linked. Hybridization or
detection was carried out at 40 8C according to manufacturer’s directions using UltrahybTM buffer and 32P-labelled
oligonucleotides. For detecting the ST3 s2 dsRNA, the oligonucleotide S2.3 complementary to nucleotides near the 3V end of
the s2 RNAwas used. For detecting the s2/CAT ssRNA, the oligonucleotide CAT.1 complementary to CAT gene was used. The
membrane was used to expose X-ray film.
Recombinant virus purification
Forty-eight hours following lipofection of L929 or L-ST3.S2 cells with the indicated ssRNAs, protein translation mixture, and
infection with reovirus serotype 2 helper virus, total cell monolayers were harvested. Serial 10-fold dilutions were prepared from
these lysates and monolayers of L929 or L-ST3.S2 cells were infected. After incubation at 37 8C for 5 days, neutral red was added
24 h before counting plaques (Roner et al., 1997). Visualized plaques were selected using Pasteur pipettes and placed in 1 ml
MEM without serum. Serial 10-fold dilutions were prepared from these individual virus isolates and monolayers of L929 or L-
ST3.S2 cells were infected. After incubation at 37 8C for 5 days, neutral red was added 24 h before counting plaques (Roner et al.,
1997). Visualized plaques were selected using Pasteur pipettes and placed in 1 ml MEMwithout serum. This plaque-purification
process was repeated a third time. The dsRNA genomes of each three-time plaque-purified isolate were then analyzed by SDS-
PAGE. In summary, individual wells of 96-well plates of L929 or L-ST3.S2 cells were infected with 50 Al of each isolate. After
incubation at 37 C for 24 h, 1ACi 32P orthophosphate was added to each well. After an additional 24 h, 50 Al of 2 Laemmli
sample buffer was added to each well and the plate stored at20 8C. The plate was heated to 65 8C for 10 min and 10 Al of each
well loaded onto a 7.5% SDS-PAGE gel and electrophoresis carried out for 2650 V/h. The gels were immediately dried and used
to expose X-ray film.
Sequencing of cDNA templates and recombinant viruses
All cDNA templates were sequenced to confirm the presence of the desired mutations. The T7-generated ssRNAs were
sequenced using two methods: the 5V 200 nucleotides sequenced using reverse transcriptase (RT) and a complementary primer,
the 3V ends first poly-A tailed using yeast poly-A polymerase, then sequenced using RT and an oligo-T primer, as described
(Roner and Joklik, 2001; Wiener et al., 1989). Following purification, all recombinant reoviruses were propagated and the S2
dsRNA genome segments sequenced directly using reverse transcriptase as described (Wiener et al., 1989).References
Antczak, J.B., Joklik, W.K., 1992. Reovirus genome segment assortment
into progeny genomes studied by the use of monoclonal antibodies
directed against reovirus proteins. Virology 187 (2), 760–776.
Antczak, J.B., Chmelo, R., Pickup, D.J., Joklik, W.K., 1982. Sequence at
both termini of the 10 genes of reovirus serotype 3 (strain Dearing).
Virology 121, 307–319.Barro,M.,Mandiola,P.,Chen,D.,Patton,J.T.,Spencer,E.,2001.Identification
of sequences in rotavirus mRNAs important for minus strand synthesis
using antisense oligonucleotides. Virology 288 (1), 71–80.
Been, M.D., Perrotta, A.T., Rosentein, S.P., 1992. Sequence at both termini
of the 10 genes of reovirus serotype 3 (strain Dearing). Biochemistry
31, 11843–11852.
Coombs, K.M., 1998. Temperature-sensitive mutants of reovirus. Curr. Top.
Microbiol. Immunol. 233, 69–107.
M.R. Roner et al. / Virology 329 (2004) 348–360360Deo, R.C., Groft, C.M., Rajashankar, K.R., Burley, S.K., 2002. Recognition
of the rotavirus mRNA 3V consensus by an asymmetric NSP3
homodimer. Cell 108 (1), 71–91.
Estes, M.K., 1996. Rotaviruses and their replication. In: Fields, B.N.,
Knipe, D., et al. (Eds.), Fundamental Virology, 3rd ed., vol. 2.
Lippincott-Raven, Philadelphia, pp. 731–761.
Fields, B.N., Laskov, R., Scharff, M.D., 1972. Temperature-sensitive
mutants of reovirus type 3: studies on the synthesis of viral peptides.
Virology 50 (1), 209–215.
Gaillard Jr., R.K., Joklik, W.K., 1985. The relative translation efficiencies
of reovirus messenger RNAs. Virology 147, 336–348.
Gunning, P., Leavitt, J., Muscat, G., Ng, S.Y., Kedes, L., 1987. A
human beta-actin expression vector system directs high-level
accumulation of antisense transcripts. Proc. Natl. Acad. Sci. U.S.A.
84, 4831–4835.
Ito, Y., Joklik, W.K., 1972. Temperature-sensitive mutants of reovirus. 3.
Evidence that mutants of group D (bRNA-negativeQ) are structural
polypeptide mutants. Virology 50, 189–202.
Joklik, W.K., Roner, M.R., 1995. What reassorts when reovirus genome
segments reassort? J. Biol. Chem. 270, 4181–4184.
Kainov, D.E., Butcher, S.J., Bamford, D.H., Tuma, R., 2003. Conserved
intermediates on the assembly pathway of double-stranded RNA
bacteriophages. J. Mol. Biol. 328 (4), 791–804.
Mindich, L., 1999. Reverse genetics of dsRNA bacteriophage phi 6. Adv.
Virus Res. 53, 341–353.
Moody, M.D., Joklik, W.K., 1989. The function of reovirus proteins during
the reovirus multiplication cycle: analysis using monoreassortants.
Virology 173 (2), 437–446.
Patton, J.T., Spencer, E., 2000. Genome replication and packaging
of segmented double-stranded RNA viruses. Virology 277,
217–225.
RNAstructure, Version 3.5, Copyright 1996, 1997, 1998, 1999 by David H.Mathews, Mark E. Burkard, and Douglas H. Turner. Made possible by
the support of Isis Pharmaceuticals, Inc.
Roner, M.R., 1999. Rescue systems for dsRNAviruses of higher organisms.
Adv. Virus Res. 53, 355–367.
Roner, M.R., 2001. Reovirus reverse genetics: incorporation of the CAT
gene into the reovirus genome. Proc. Natl. Acad. Sci. U.S.A. 98,
8036–8041.
Roner, M.R., Sutphin, L.A., Joklik, W.K., 1990. Reovirus RNA is
infectious. Virology 179, 845–852.
Roner, M.R., Lin, P.-N., Nepluev, I., Kong, L.-J., Joklik, W.K., 1995.
Identification of signals required for the insertion of heterologous
genome segments into the reovirus genome. Proc. Natl. Acad. Sci.
U.S.A. 92, 12362–12366.
Roner, M.R., Nepluev, I., Sherry, B., Joklik, W.K., 1997. Construction and
characterization of a reovirus double temperature-sensitive mutant.
Proc. Natl. Acad. Sci. U.S.A. 94, 6826–6830.
Roy, P., 1996. Orbiviruses and their replication. In: Fields, B.N., Knipe, D.,
Howley, et al. (Eds.), Virology, 3rd ed., vol. 2. Lippincott-Raven,
Philadelphia, pp. 1709–1734.
Skehel, J.J., Joklik, W.K., 1969. Studies on the in vitro transcription of
reovirus RNA catalyzed by reovirus cores. Virology 39, 822–831.
Shatkin, A.J., 1968. Separation of ten reovirus genome segments by
polyacrylamide gel electrophoresis. J. Virol. 2, 986–991.
Smith, R.E., Zweerink, H.J., Joklik, W.K., 1969. Polypeptide components
of virions, top component and cores of reovirus type 3. Virology 39 (4),
791–810.
Spendlove, R.S., McClain, M.E., Lennette, E.H., 1970. Enhancement of
reovirus infectivity by extracellular removal or alteration of the virus
capsid by proteolytic enzymes. J. Gen. Virol. 8, 83–94.
Wiener, J.R., McLaughlan, T., Joklik, W.K., 1989. The sequences of the S2
genome segments of reovirus serotype 3 and of the dsRNA-negative
mutant ts447. Virology 170, 340–341.
